Table of Content - Morphine, Buprenorphine, And Other Drugs Market

Morphine, buprenorphine, and other similar drugs are known as opioid drugs. Opium is dark brown, resinous material obtained from poppy capsule called opium containing alkaloids. Opioids include morphine, buprenorphine, noscapine, thebaine, etrophine, and other similar substances. Morphine is principle alkaloid in opium and is described prototype of this class of drugs. Opioids have sedative and analgesic effects, and are commonly used for pain management. Opioids are commonly indicated in traumatic, visceral, ischaemic, postoperative burn, and cancer pain. The growth in the market can be primarily attributed to the growing prevalence of cancer worldwide.

Market Dynamics

The key drivers contributing to the global morphine, buprenorphine and other drug market's growth is the increase in prevalence of diseases such as cancer, chronic pain (post-surgical pain, lower back pain), arthritis, and fibromyalgia. Several narcotic drugs are recommended for the management of moderate to severe pain in cancer patients. For instance, according to Centers for Disease Control and Prevention (CDC) cancer is one of leading causes of deaths in the U.S. Furthermore, according to U.S. Cancer Statistics of 2021 in 2018 1,708,923 Americans were diagnosed with cancer. Thus, owing to prevalence of cancer and use of opioids for treatment of cancer is expected to drive the market growth.

Key features of the study

This report provides an in-depth analysis of the morphine, buprenorphine, and other drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the morphine, buprenorphine and other drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Purdue Pharma, Sun Pharmaceuticals, Pfizer Inc. , West Ward Pharmaceuticals, Teva Pharmaceuticals, Piramal Pharmaceuticals, Hikama Pharmaceuticals, Indivior PLC, Oreoxo AB, Camurus AB, and Novartis
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The morphine, buprenorphine, and other drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global morphine, buprenorphine, and other drugs market

Market Segmentation

By Drug (Revenue, USD Bn, 2021-2033)
- Morphine
- Buprenorphine
- Noscapin
- Thebaine
- Etrophine
By Application (Revenue, USD Bn, 2021-2033)
- Pain Management
- Opioid Addiction Treatment
- Others
By Route Of Administration (Revenue, USD Bn, 2021-2033)
- Injectable
- Oral
- Transdermal
By Distribution Channel (Revenue, USD Bn, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Others
By Region (Revenue, USD Bn, 2021-2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - Central Africa
  - North Africa
Key Players
- Purdue Pharma
- Sun Pharmaceuticals
- Pfizer Inc.
- West Ward Pharmaceuticals
- Teva Pharmaceuticals
- Piramal Pharmaceuticals
- Hikama Pharmaceuticals
- Indivior PLC
- Oreoxo AB
- Camurus AB
- Novartis

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Drug
  - Market Snapshot, By Application
  - Market Snapshot, By Route Of Administration
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter’s Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
Morphine, Buprenorphine, and Other Drugs Market, By Drug, 2021 – 2033, (USD Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022– 2033
  - Segment Trends
- Morphine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Buprenorphine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Noscapine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Thebaine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Etrophine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
Morphine, Buprenorphine, and Other Drugs Market, By Application, 2021 – 2033, (USD Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022– 2033
  - Segment Trends
- Pain Management
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Opioid Addiction Treatment
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
Morphine, Buprenorphine, and Other Drugs Market, By Route Of Administration, 2021 – 2033, (USD Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022– 2033
  - Segment Trends
- Injectable
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Transdermal
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
Morphine, Buprenorphine, and Other Drugs Market, By Distribution Channel, 2021 – 2033, (USD Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion)
Morphine, Buprenorphine, and Other Drugs Market, By Region, 2021 – 2033, (USD Billion)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Regions, 2022–2033
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Billion)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
  - Purdue Pharma
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Sun Pharmaceuticals
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Pfizer Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - West Ward Pharmaceuticals
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Teva Pharmaceuticals
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Piramal Pharmaceuticals
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Hikama Pharmaceuticals
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Indivior PLC
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Oreoxo AB
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Camurus AB
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Novartis
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
- Analyst Views
Section
- References
- Research Methodology
- About Us

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE